Autologous platelet‐rich plasma showed no clear difference in chronic wounds (all) completely healed compared with standard care with/without placebo (low certainty).
Autologous platelet‐rich plasma may leads to higher chronic wounds (diabetic foot ulcers) completely healed compared with standard care with/without placebo (low certainty).
Autologous platelet‐rich plasma showed no clear difference in chronic wounds (venous leg ulcers) completely healed compared with standard care with/without placebo (low certainty).
It is very uncertain whether autologous platelet‐rich plasma changes adverse events compared with standard care with/without placebo (very low certainty).
It is very uncertain whether intrauterine infusion of autologous platelet‐rich plasma changes live birth (or ongoing pregnancy compared with intrauterine infusion of granulocyte colony‐stimulating factor (very low certainty).
It is very uncertain whether intrauterine infusion of autologous platelet‐rich plasma changes miscarriage compared with intrauterine infusion of granulocyte colony‐stimulating factor (very low certainty).
It is very uncertain whether intrauterine infusion of autologous platelet‐rich plasma changes clinical pregnancy compared with intrauterine infusion of granulocyte colony‐stimulating factor (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether intrauterine injection of autologous platelet‐rich plasma changes live birth (or ongoing pregnancy) compared with no intervention (very low certainty).
It is very uncertain whether intraovarian injection of autologous platelet‐rich plasma changes ongoing pregnancy compared with no intervention (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether intraovarian injection of autologous platelet‐rich plasma changes clinical pregnancy compared with no intervention (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether intrauterine injection of autologous platelet‐rich plasma changes miscarriage compared with no intervention (very low certainty).
It is very uncertain whether intrauterine injection of autologous platelet‐rich plasma changes clinical pregnancy compared with no intervention (very low certainty).
It is very uncertain whether intrauterine injection of autologous platelet‐rich plasma changes adverse events: ectopic pregnancy compared with no intervention (very low certainty).
Intrauterine infusion/injection of autologous platelet‐rich plasma may leads to higher adverse events: preterm delivery compared with no intervention or placebo (low certainty).
It is very uncertain whether intrauterine infusion/injection of autologous platelet‐rich plasma changes live birth (or ongoing pregnancy) compared with no intervention or placebo (very low certainty).
It is very uncertain whether intrauterine infusion/injection of autologous platelet‐rich plasma changes miscarriage compared with no intervention or placebo (very low certainty).
It is very uncertain whether intrauterine infusion/injection of autologous platelet‐rich plasma changes clinical pregnancy compared with no intervention or placebo (very low certainty).
The findings closest to your search, judged one by one by TypeSafe's Jev model.